Work

Editorial: Mechanistic and therapeutic advances in antibody-mediated rejection: reasons to be optimistic

Year: 2022

Type: editorial

Abstract: aNephrology Unit, Department of Health Sciences, Università degli Studi di Milano, Italy bTranslational Transplant Research Center (TTRC), Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA Correspondence to Paolo Cravedi, MD, PhD, Icahn School of Medicine at Mount Sinai, 1 Levy Place, New York, NY 10029, USA. Tel: +1 212 241 3349; fax: +1 212 987 0389; e-mail: [email protected]

Source: Current Opinion in Organ Transplantation

DOI: 10.1097/mot.0000000000001020

Authors: Manuel Alfredo Podestà, Paolo Cravedi

Institutions: University of Milan, Icahn School of Medicine at Mount Sinai

Language: English

Topic: Renal Transplantation Outcomes and Treatments

Subfield: Transplantation

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Institute of Allergy and Infectious Diseases